مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| شاخص هاروی-برادشاو× | امتیاز مایو برای کولیت اولسراتیو× | |
|---|---|---|
| حوزه | گوارش | گوارش |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 1980 | 1987 |
| پدیدآور≠ | R. F. Harvey and J. M. Bradshaw | Schroeder, K. W., Tremaine, W. J., and Ilstrup, D. M. |
| نوع | Clinician-rated | Clinician-rated |
| منبع بنیادین≠ | Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514. DOI ↗ | Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987). Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. New England Journal of Medicine, 317(26), 1625–1629. DOI ↗ |
| نامهای دیگر≠ | HBI | Mayo Clinic Score, UC Mayo Score |
| مرتبط≠ | 5 | 4 |
| خلاصه≠ | The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response. | The Mayo Score is a validated tool for assessing disease activity in ulcerative colitis, integrating clinical symptoms and endoscopic findings. Introduced by Schroeder and colleagues in 1987, it has become the reference standard for UC activity assessment in clinical trials and practice. The score combines stool frequency, rectal bleeding, overall physician global assessment, and endoscopic subscore into a single 0–12 scale. |
| ScholarGateمجموعهداده ↗ |
|
|